1. General Resources
Practical Tools for Prescribing and Promoting Buprenorphine in Primary Care Settings
Guide to Medication for Treating Alcohol Use Disorder
SAMHSA TIP 35: Enhancing Motivation for Change in SUD Treatment SAMHSA TIP 35
Evidence Based Resource Guide on Treatment of Stimulant Use Disorder
Nevada DPBH Overdose Prevention
ATTC Educational Packages for OUD
AHRQ Integration Academy Substance Use Resources
Nevada State Opioid Response (SOR)
Nevada Controlled Substance Abuse Prevention Act (AB 474)
AB474 Toolkit - Nevada State Medical Association
Medications for Opioid Use Disorder Save Lives
Medication for the Treatment of Alcohol Use Disorder
Enhancing Motivation for Change in Substance Use Disorder Treatment
Treatment of Stimulant Use Disorders - Evidence-Based Resource Guide Series
Executive Summary Medications for Opioid Use Disorder
Medications for Opioid Use Disorder
Primary Care-Based Models for OUD
Standard Framework for Levels of Integrated Care
How to Become a Buprenorphine Waivered Practitioner to treat OUD
-
New Buprenorphine Practice Guidelines, Expanding Access to Treatment for Opioid Use Disorder - HHS
-
FAQs About the New Buprenorphine Practice Guidelines - SAMHSA
X-Waiver Training - Providers Clinical Support System (PCSS)
2. Planning Documents
3. Sample Workflows & Templates
MSHC MAT Sample Workflow Program Design - Patient Phases
Suboxone/buprenorphine Therapy Progress Report
Epic “Dot Phrases” for Substance Use Navigators
MSHC Sample MAT Workflow for Referral
MSHC MAT Sample Workflow Program Design
Buprenorphine Home Initiation vs Office Initiation Considerations
4. Patient Treatment
Agreements
5. Confidentiality Considerations for Primary Care
7. Sample Protocols, Procedures, & Policies
Elements of an OBOT Diversion Control Plan
SAMHSA Diversion Control Protocol
How to Prepare for a DEA Inspection
Guidance on Billing for Office-Based Treatment of OUD
Billing and Coding: Medication Assisted Treatment
Navigator and Clinician Champion Collaboration
Elements of an OBOT Diversion Control Plan
SAMHSA Diversion Control Protocol
How to Prepare for a DEA Inspection
Heartland Sample Urine Drug Testing
Heartland Sample Late Arrival Policy
Heartland Sample Referral Protocol
MSHC Sample Policy Sanctions and Incentives
BMC Sample Urine Toxicology Policy
BMC Sample Lost, Stolen, or Destroyed Buprenorphine Policy
9. Harm Reduction Resources
6. Clinical Tools
DSM-5 Criteria for Diagnosis of OUD
Clinical Opiate Withdrawal Scale
ASAM Drug Testing Pocket Guide
Naloxone Distribution in Nevada
Patient Counseling Tool for XR Naltrexone
Reducing Naltrexone Injection Site Reactions
Treating Pregnant and Postpartum Women and Infants
Opioid Use, Misuse, and Overdose in Women
Provider Clinical Support System (PCSS)
ED Bridge - Emergency Dept. Initiation of MOUD
8. Patient Education
10. EHR Resources
11. Quality Assurance and Peer Review Tools
13. OUD Treatment in Patients with HIV or Hepatitis
12. OUD Treatment for Women & Newborns
Consensus Statement on Obstetric Care for Women with OUD
Patient Factsheet - OUD Treatment for Pregnant and Post-Natal Women
Patient Factsheet - OUD Treatment during Pregnancy
Patient Factsheet - NAS Treatment
Patient Factsheet - Intro to OUD Treatment during Pregnancy
Summary of Literature on Treating Pregnant Women, Parents and their Children
Treatment recommendations and algorithms for HCV
Drug interactions in the treatment of HCV
Drug interactions in the treatment of HIV
Nevada Medicaid Hepatitis C Agents Prior Authorization Request Form
Southern Nevada Health District Hepatitis C Patient Clinics and Resources
Nevada Statewide Hepatitis Resource Directory
Concurrent Treatment of HIV and OUD
Considerations for MAT in Patients with HIV